JP2009526084A - 可溶性ＩＬ−１７ＲＣｘ４および炎症における使用法 - Google Patents

Info

Publication number

JP2009526084A

JP2009526084A JP2008554516A JP2008554516A JP2009526084A JP 2009526084 A JP2009526084 A JP 2009526084A JP 2008554516 A JP2008554516 A JP 2008554516A JP 2008554516 A JP2008554516 A JP 2008554516A JP 2009526084 A JP2009526084 A JP 2009526084A

Authority

JP

Japan

Prior art keywords

disease

seq

inflammatory

polypeptide

antibody

Prior art date

2006-02-10

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 230000004054 inflammatory process Effects 0.000 title claims abstract description 35
• 206010061218 Inflammation Diseases 0.000 title claims abstract description 33
• 102000013691 Interleukin-17 Human genes 0.000 claims abstract description 268
• 108050003558 Interleukin-17 Proteins 0.000 claims abstract description 268
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 57
• 201000010099 disease Diseases 0.000 claims abstract description 56
• 230000000694 effects Effects 0.000 claims abstract description 46
• 230000001603 reducing effect Effects 0.000 claims abstract description 13
• 102100035012 Interleukin-17 receptor C Human genes 0.000 claims abstract 15
• 101710186068 Interleukin-17 receptor C Proteins 0.000 claims abstract 7
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 428
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 366
• 229920001184 polypeptide Polymers 0.000 claims description 339
• 108020003175 receptors Proteins 0.000 claims description 208
• 238000000034 method Methods 0.000 claims description 183
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 93
• 125000000539 amino acid group Chemical group 0.000 claims description 63
• 239000012634 fragment Substances 0.000 claims description 62
• 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 32
• 239000005557 antagonist Substances 0.000 claims description 31
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 27
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 27
• 208000027866 inflammatory disease Diseases 0.000 claims description 27
• 208000037487 Endotoxemia Diseases 0.000 claims description 22
• 208000006673 asthma Diseases 0.000 claims description 22
• 206010003246 arthritis Diseases 0.000 claims description 21
• 230000001575 pathological effect Effects 0.000 claims description 21
• 230000004968 inflammatory condition Effects 0.000 claims description 20
• 230000002757 inflammatory effect Effects 0.000 claims description 19
• 208000015181 infectious disease Diseases 0.000 claims description 18
• 101001019602 Homo sapiens Interleukin-17 receptor C Proteins 0.000 claims description 17
• 201000004681 Psoriasis Diseases 0.000 claims description 17
• 230000001154 acute effect Effects 0.000 claims description 16
• 230000000770 proinflammatory effect Effects 0.000 claims description 16
• 206010040070 Septic Shock Diseases 0.000 claims description 15
• 239000003550 marker Substances 0.000 claims description 15
• 241000124008 Mammalia Species 0.000 claims description 14
• 239000003814 drug Substances 0.000 claims description 14
• 206010009900 Colitis ulcerative Diseases 0.000 claims description 12
• 108090000790 Enzymes Proteins 0.000 claims description 12
• 201000006704 Ulcerative Colitis Diseases 0.000 claims description 12
• 239000000203 mixture Substances 0.000 claims description 12
• 230000002829 reductive effect Effects 0.000 claims description 12
• 102000004190 Enzymes Human genes 0.000 claims description 11
• 206010040047 Sepsis Diseases 0.000 claims description 10
• 230000001684 chronic effect Effects 0.000 claims description 10
• 230000006320 pegylation Effects 0.000 claims description 10
• 208000011231 Crohn disease Diseases 0.000 claims description 9
• 206010012438 Dermatitis atopic Diseases 0.000 claims description 9
• 201000008937 atopic dermatitis Diseases 0.000 claims description 9
• 208000037976 chronic inflammation Diseases 0.000 claims description 9
• 206010044248 Toxic shock syndrome Diseases 0.000 claims description 8
• 231100000650 Toxic shock syndrome Toxicity 0.000 claims description 8
• 208000037893 chronic inflammatory disorder Diseases 0.000 claims description 8
• 229940079593 drug Drugs 0.000 claims description 8
• 239000000758 substrate Substances 0.000 claims description 7
• 239000003053 toxin Substances 0.000 claims description 7
• 231100000765 toxin Toxicity 0.000 claims description 5
• 229940126619 mouse monoclonal antibody Drugs 0.000 claims description 4
• 239000006249 magnetic particle Substances 0.000 claims description 3
• 230000007423 decrease Effects 0.000 claims 1
• 230000001568 sexual effect Effects 0.000 claims 1
• 102000004127 Cytokines Human genes 0.000 abstract description 49
• 108090000695 Cytokines Proteins 0.000 abstract description 49
• 230000003472 neutralizing effect Effects 0.000 abstract description 29
• 230000002401 inhibitory effect Effects 0.000 abstract description 12
• 230000003042 antagnostic effect Effects 0.000 abstract description 10
• 230000002452 interceptive effect Effects 0.000 abstract description 10
• 108090000623 proteins and genes Proteins 0.000 description 217
• 210000004027 cell Anatomy 0.000 description 198
• 102000005962 receptors Human genes 0.000 description 184
• 102000004169 proteins and genes Human genes 0.000 description 115
• 235000018102 proteins Nutrition 0.000 description 110
• 235000001014 amino acid Nutrition 0.000 description 94
• 230000027455 binding Effects 0.000 description 88
• 238000009739 binding Methods 0.000 description 83
• 229940024606 amino acid Drugs 0.000 description 77
• 102000053602 DNA Human genes 0.000 description 73
• 108020004414 DNA Proteins 0.000 description 72
• 150000001413 amino acids Chemical class 0.000 description 71
• 102000039446 nucleic acids Human genes 0.000 description 69
• 108020004707 nucleic acids Proteins 0.000 description 69
• 150000007523 nucleic acids Chemical class 0.000 description 69
• 239000003446 ligand Substances 0.000 description 61
• 230000014509 gene expression Effects 0.000 description 55
• 102000037865 fusion proteins Human genes 0.000 description 54
• 108020001507 fusion proteins Proteins 0.000 description 54
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 48
• 125000003729 nucleotide group Chemical group 0.000 description 47
• 239000000427 antigen Substances 0.000 description 46
• 108091007433 antigens Proteins 0.000 description 46
• 102000036639 antigens Human genes 0.000 description 46
• 239000002773 nucleotide Substances 0.000 description 45
• 210000001519 tissue Anatomy 0.000 description 39
• 206010039073 rheumatoid arthritis Diseases 0.000 description 31
• 108020004635 Complementary DNA Proteins 0.000 description 29
• 230000000890 antigenic effect Effects 0.000 description 29
• 239000013604 expression vector Substances 0.000 description 29
• 238000004519 manufacturing process Methods 0.000 description 28
• 239000013598 vector Substances 0.000 description 28
• 238000010804 cDNA synthesis Methods 0.000 description 26
• 239000002299 complementary DNA Substances 0.000 description 26
• 230000000295 complement effect Effects 0.000 description 25
• 102000040430 polynucleotide Human genes 0.000 description 25
• 108091033319 polynucleotide Proteins 0.000 description 25
• 239000002157 polynucleotide Substances 0.000 description 25
• 238000006467 substitution reaction Methods 0.000 description 25
• 210000001744 T-lymphocyte Anatomy 0.000 description 24
• 238000004458 analytical method Methods 0.000 description 23
• 108020004999 messenger RNA Proteins 0.000 description 23
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 22
• 108010076504 Protein Sorting Signals Proteins 0.000 description 21
• 229920001223 polyethylene glycol Polymers 0.000 description 21
• 238000003752 polymerase chain reaction Methods 0.000 description 21
• 238000012216 screening Methods 0.000 description 21
• 241000894007 species Species 0.000 description 21
• 239000000126 substance Substances 0.000 description 21
• 238000000746 purification Methods 0.000 description 20
• 230000003248 secreting effect Effects 0.000 description 20
• 108020004705 Codon Proteins 0.000 description 19
• 239000002202 Polyethylene glycol Substances 0.000 description 19
• 238000003556 assay Methods 0.000 description 19
• 230000004927 fusion Effects 0.000 description 19
• 230000001404 mediated effect Effects 0.000 description 19
• 241000588724 Escherichia coli Species 0.000 description 18
• 230000003302 anti-idiotype Effects 0.000 description 18
• 238000013459 approach Methods 0.000 description 18
• 102000003675 cytokine receptors Human genes 0.000 description 18
• 108010057085 cytokine receptors Proteins 0.000 description 18
• 230000001105 regulatory effect Effects 0.000 description 17
• 229920002477 rna polymer Polymers 0.000 description 16
• 230000001225 therapeutic effect Effects 0.000 description 16
• 241000699666 Mus <mouse, genus> Species 0.000 description 15
• 239000002158 endotoxin Substances 0.000 description 15
• 230000003834 intracellular effect Effects 0.000 description 15
• 229920006008 lipopolysaccharide Polymers 0.000 description 15
• 229920000642 polymer Polymers 0.000 description 15
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 14
• 108091028043 Nucleic acid sequence Proteins 0.000 description 14
• 238000010367 cloning Methods 0.000 description 14
• 238000011282 treatment Methods 0.000 description 14
• 241000701447 unidentified baculovirus Species 0.000 description 14
• 206010028980 Neoplasm Diseases 0.000 description 13
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 13
• 230000028993 immune response Effects 0.000 description 13
• 238000001727 in vivo Methods 0.000 description 13
• 238000013518 transcription Methods 0.000 description 13
• 230000035897 transcription Effects 0.000 description 13
• 102000004889 Interleukin-6 Human genes 0.000 description 12
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 12
• 230000009471 action Effects 0.000 description 12
• 230000006378 damage Effects 0.000 description 12
• 108020001756 ligand binding domains Proteins 0.000 description 12
• 230000037361 pathway Effects 0.000 description 12
• 241000196324 Embryophyta Species 0.000 description 11
• 108090001005 Interleukin-6 Proteins 0.000 description 11
• 241001452677 Ogataea methanolica Species 0.000 description 11
• 239000000556 agonist Substances 0.000 description 11
• 230000002391 anti-complement effect Effects 0.000 description 11
• 108010008730 anticomplement Proteins 0.000 description 11
• 238000003776 cleavage reaction Methods 0.000 description 11
• 238000005516 engineering process Methods 0.000 description 11
• 229940088598 enzyme Drugs 0.000 description 11
• 230000006870 function Effects 0.000 description 11
• 238000000338 in vitro Methods 0.000 description 11
• 230000004044 response Effects 0.000 description 11
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
• -1 aromatic amino acid Chemical class 0.000 description 10
• 230000008901 benefit Effects 0.000 description 10
• 201000011510 cancer Diseases 0.000 description 10
• 210000001072 colon Anatomy 0.000 description 10
• 239000000833 heterodimer Substances 0.000 description 10
• 230000003993 interaction Effects 0.000 description 10
• 210000004962 mammalian cell Anatomy 0.000 description 10
• 239000000178 monomer Substances 0.000 description 10
• 230000035772 mutation Effects 0.000 description 10
• 239000000523 sample Substances 0.000 description 10
• 230000007017 scission Effects 0.000 description 10
• 238000010561 standard procedure Methods 0.000 description 10
• 238000012546 transfer Methods 0.000 description 10
• 229920003169 water-soluble polymer Polymers 0.000 description 10
• 208000023275 Autoimmune disease Diseases 0.000 description 9
• 108060003951 Immunoglobulin Proteins 0.000 description 9
• 108010017525 Interleukin-17 Receptors Proteins 0.000 description 9
• 102000004554 Interleukin-17 Receptors Human genes 0.000 description 9
• 230000004913 activation Effects 0.000 description 9
• 230000015572 biosynthetic process Effects 0.000 description 9
• 150000001875 compounds Chemical class 0.000 description 9
• 230000000875 corresponding effect Effects 0.000 description 9
• 239000000710 homodimer Substances 0.000 description 9
• 102000018358 immunoglobulin Human genes 0.000 description 9
• 125000005647 linker group Chemical group 0.000 description 9
• 210000004379 membrane Anatomy 0.000 description 9
• 239000012528 membrane Substances 0.000 description 9
• 201000006417 multiple sclerosis Diseases 0.000 description 9
• 239000013612 plasmid Substances 0.000 description 9
• 230000011664 signaling Effects 0.000 description 9
• 208000024891 symptom Diseases 0.000 description 9
• 238000003786 synthesis reaction Methods 0.000 description 9
• 102000008186 Collagen Human genes 0.000 description 8
• 108010035532 Collagen Proteins 0.000 description 8
• 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 8
• 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 8
• 241000699670 Mus sp. Species 0.000 description 8
• 241000700605 Viruses Species 0.000 description 8
• 230000001580 bacterial effect Effects 0.000 description 8
• 238000006243 chemical reaction Methods 0.000 description 8
• 229920001436 collagen Polymers 0.000 description 8
• 231100000433 cytotoxic Toxicity 0.000 description 8
• 230000001472 cytotoxic effect Effects 0.000 description 8
• 238000012217 deletion Methods 0.000 description 8
• 230000037430 deletion Effects 0.000 description 8
• 210000002865 immune cell Anatomy 0.000 description 8
• 208000014674 injury Diseases 0.000 description 8
• 210000004698 lymphocyte Anatomy 0.000 description 8
• 239000011159 matrix material Substances 0.000 description 8
• 239000000047 product Substances 0.000 description 8
• 241000894006 Bacteria Species 0.000 description 7
• 108010047041 Complementarity Determining Regions Proteins 0.000 description 7
• 208000009386 Experimental Arthritis Diseases 0.000 description 7
• 108010050904 Interferons Proteins 0.000 description 7
• 102000014150 Interferons Human genes 0.000 description 7
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 7
• 201000001263 Psoriatic Arthritis Diseases 0.000 description 7
• 208000036824 Psoriatic arthropathy Diseases 0.000 description 7
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 7
• 238000005917 acylation reaction Methods 0.000 description 7
• 238000001042 affinity chromatography Methods 0.000 description 7
• 210000000612 antigen-presenting cell Anatomy 0.000 description 7
• 239000011616 biotin Substances 0.000 description 7
• 229960002685 biotin Drugs 0.000 description 7
• 230000008859 change Effects 0.000 description 7
• 206010009887 colitis Diseases 0.000 description 7
• 239000012636 effector Substances 0.000 description 7
• 230000002068 genetic effect Effects 0.000 description 7
• 210000002443 helper t lymphocyte Anatomy 0.000 description 7
• 230000001965 increasing effect Effects 0.000 description 7
• MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 7
• 238000002703 mutagenesis Methods 0.000 description 7
• 231100000350 mutagenesis Toxicity 0.000 description 7
• 201000008482 osteoarthritis Diseases 0.000 description 7
• 238000002823 phage display Methods 0.000 description 7
• 238000002360 preparation method Methods 0.000 description 7
• 230000028327 secretion Effects 0.000 description 7
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 7
• 238000002560 therapeutic procedure Methods 0.000 description 7
• 230000002103 transcriptional effect Effects 0.000 description 7
• 230000014616 translation Effects 0.000 description 7
• 206010009944 Colon cancer Diseases 0.000 description 6
• 241000238631 Hexapoda Species 0.000 description 6
• 241001465754 Metazoa Species 0.000 description 6
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
• 108091034117 Oligonucleotide Proteins 0.000 description 6
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 6
• 102100040247 Tumor necrosis factor Human genes 0.000 description 6
• 208000027418 Wounds and injury Diseases 0.000 description 6
• 210000003719 b-lymphocyte Anatomy 0.000 description 6
• 210000000845 cartilage Anatomy 0.000 description 6
• 230000001413 cellular effect Effects 0.000 description 6
• 230000003394 haemopoietic effect Effects 0.000 description 6
• 229940027941 immunoglobulin g Drugs 0.000 description 6
• 230000028709 inflammatory response Effects 0.000 description 6
• 229940079322 interferon Drugs 0.000 description 6
• 210000003734 kidney Anatomy 0.000 description 6
• 229920002521 macromolecule Polymers 0.000 description 6
• 210000000056 organ Anatomy 0.000 description 6
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 6
• 230000008569 process Effects 0.000 description 6
• 238000005932 reductive alkylation reaction Methods 0.000 description 6
• 238000012552 review Methods 0.000 description 6
• 230000036303 septic shock Effects 0.000 description 6
• 230000019491 signal transduction Effects 0.000 description 6
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 6
• 230000008685 targeting Effects 0.000 description 6
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 5
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 5
• 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 5
• 206010033645 Pancreatitis Diseases 0.000 description 5
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 5
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 5
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 5
• 230000010933 acylation Effects 0.000 description 5
• 150000001299 aldehydes Chemical class 0.000 description 5
• 230000002917 arthritic effect Effects 0.000 description 5
• 239000011324 bead Substances 0.000 description 5
• 235000020958 biotin Nutrition 0.000 description 5
• 210000000988 bone and bone Anatomy 0.000 description 5
• 210000004899 c-terminal region Anatomy 0.000 description 5
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
• 238000004587 chromatography analysis Methods 0.000 description 5
• 230000008878 coupling Effects 0.000 description 5
• 238000010168 coupling process Methods 0.000 description 5
• 238000005859 coupling reaction Methods 0.000 description 5
• 238000001514 detection method Methods 0.000 description 5
• 230000004069 differentiation Effects 0.000 description 5
• 150000002148 esters Chemical class 0.000 description 5
• 210000003527 eukaryotic cell Anatomy 0.000 description 5
• 230000012010 growth Effects 0.000 description 5
• 210000004408 hybridoma Anatomy 0.000 description 5
• 230000003053 immunization Effects 0.000 description 5
• 239000007924 injection Substances 0.000 description 5
• 238000002347 injection Methods 0.000 description 5
• 238000002955 isolation Methods 0.000 description 5
• 210000001503 joint Anatomy 0.000 description 5
• 210000003292 kidney cell Anatomy 0.000 description 5
• 208000017169 kidney disease Diseases 0.000 description 5
• 230000002147 killing effect Effects 0.000 description 5
• 239000011347 resin Substances 0.000 description 5
• 229920005989 resin Polymers 0.000 description 5
• 238000002741 site-directed mutagenesis Methods 0.000 description 5
• 239000007787 solid Substances 0.000 description 5
• 235000000346 sugar Nutrition 0.000 description 5
• 238000012360 testing method Methods 0.000 description 5
• 229940124597 therapeutic agent Drugs 0.000 description 5
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 5
• 241000701161 unidentified adenovirus Species 0.000 description 5
• 201000001320 Atherosclerosis Diseases 0.000 description 4
• 108090000994 Catalytic RNA Proteins 0.000 description 4
• 241000282412 Homo Species 0.000 description 4
• 102000000589 Interleukin-1 Human genes 0.000 description 4
• 108010002352 Interleukin-1 Proteins 0.000 description 4
• 102100020788 Interleukin-10 receptor subunit beta Human genes 0.000 description 4
• 101710199214 Interleukin-10 receptor subunit beta Proteins 0.000 description 4
• 108060001084 Luciferase Proteins 0.000 description 4
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 4
• 241000700159 Rattus Species 0.000 description 4
• 108700008625 Reporter Genes Proteins 0.000 description 4
• 241000219061 Rheum Species 0.000 description 4
• 229920002684 Sepharose Polymers 0.000 description 4
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
• 230000006044 T cell activation Effects 0.000 description 4
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 4
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
• 239000002253 acid Substances 0.000 description 4
• 230000003110 anti-inflammatory effect Effects 0.000 description 4
• 230000004071 biological effect Effects 0.000 description 4
• 150000001720 carbohydrates Chemical class 0.000 description 4
• 230000003197 catalytic effect Effects 0.000 description 4
• 239000003638 chemical reducing agent Substances 0.000 description 4
• 238000004520 electroporation Methods 0.000 description 4
• 230000002255 enzymatic effect Effects 0.000 description 4
• 238000007429 general method Methods 0.000 description 4
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
• 239000003102 growth factor Substances 0.000 description 4
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
• 230000036039 immunity Effects 0.000 description 4
• 238000002649 immunization Methods 0.000 description 4
• 238000003018 immunoassay Methods 0.000 description 4
• 230000000984 immunochemical effect Effects 0.000 description 4
• 230000002163 immunogen Effects 0.000 description 4
• 230000005764 inhibitory process Effects 0.000 description 4
• 210000004072 lung Anatomy 0.000 description 4
• 210000002540 macrophage Anatomy 0.000 description 4
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 4
• 230000003278 mimic effect Effects 0.000 description 4
• 230000004048 modification Effects 0.000 description 4
• 238000012986 modification Methods 0.000 description 4
• 210000001616 monocyte Anatomy 0.000 description 4
• 210000000440 neutrophil Anatomy 0.000 description 4
• 201000002528 pancreatic cancer Diseases 0.000 description 4
• 208000008443 pancreatic carcinoma Diseases 0.000 description 4
• 230000007170 pathology Effects 0.000 description 4
• 238000010647 peptide synthesis reaction Methods 0.000 description 4
• 229920002704 polyhistidine Polymers 0.000 description 4
• 239000013615 primer Substances 0.000 description 4
• 230000035755 proliferation Effects 0.000 description 4
• 238000011160 research Methods 0.000 description 4
• 239000000243 solution Substances 0.000 description 4
• 210000000952 spleen Anatomy 0.000 description 4
• 125000003396 thiol group Chemical group [H]S* 0.000 description 4
• 108700012359 toxins Proteins 0.000 description 4
• 230000001131 transforming effect Effects 0.000 description 4
• 238000013519 translation Methods 0.000 description 4
• 238000012384 transportation and delivery Methods 0.000 description 4
• 230000003612 virological effect Effects 0.000 description 4
• 210000005253 yeast cell Anatomy 0.000 description 4
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 3
• 206010048998 Acute phase reaction Diseases 0.000 description 3
• 229920000936 Agarose Polymers 0.000 description 3
• 108010021809 Alcohol dehydrogenase Proteins 0.000 description 3
• 108020005544 Antisense RNA Proteins 0.000 description 3
• 239000004475 Arginine Substances 0.000 description 3
• 208000012657 Atopic disease Diseases 0.000 description 3
• 108090001008 Avidin Proteins 0.000 description 3
• 241000193830 Bacillus <bacterium> Species 0.000 description 3
• 102100035882 Catalase Human genes 0.000 description 3
• 108010053835 Catalase Proteins 0.000 description 3
• 102000053642 Catalytic RNA Human genes 0.000 description 3
• 102000000844 Cell Surface Receptors Human genes 0.000 description 3
• 108010001857 Cell Surface Receptors Proteins 0.000 description 3
• 229920002307 Dextran Polymers 0.000 description 3
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 3
• KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 3
• 102000005720 Glutathione transferase Human genes 0.000 description 3
• 108010070675 Glutathione transferase Proteins 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 208000009329 Graft vs Host Disease Diseases 0.000 description 3
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 3
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 3
• 102000016355 Granulocyte-Macrophage Colony-Stimulating Factor Receptors Human genes 0.000 description 3
• 108010092372 Granulocyte-Macrophage Colony-Stimulating Factor Receptors Proteins 0.000 description 3
• 101000998146 Homo sapiens Interleukin-17A Proteins 0.000 description 3
• 206010020751 Hypersensitivity Diseases 0.000 description 3
• 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 3
• 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 3
• 108010002350 Interleukin-2 Proteins 0.000 description 3
• 102000000588 Interleukin-2 Human genes 0.000 description 3
• 108010002386 Interleukin-3 Proteins 0.000 description 3
• 102100039064 Interleukin-3 Human genes 0.000 description 3
• 102000004890 Interleukin-8 Human genes 0.000 description 3
• 108090001007 Interleukin-8 Proteins 0.000 description 3
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
• 108090000581 Leukemia inhibitory factor Proteins 0.000 description 3
• 102000004058 Leukemia inhibitory factor Human genes 0.000 description 3
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
• 239000004472 Lysine Substances 0.000 description 3
• 102000018697 Membrane Proteins Human genes 0.000 description 3
• 108010052285 Membrane Proteins Proteins 0.000 description 3
• 208000034486 Multi-organ failure Diseases 0.000 description 3
• 208000010718 Multiple Organ Failure Diseases 0.000 description 3
• 241000699660 Mus musculus Species 0.000 description 3
• 101001019584 Mus musculus Interleukin-17 receptor C Proteins 0.000 description 3
• 101000998145 Mus musculus Interleukin-17A Proteins 0.000 description 3
• 108091008606 PDGF receptors Proteins 0.000 description 3
• 102000057297 Pepsin A Human genes 0.000 description 3
• 108090000284 Pepsin A Proteins 0.000 description 3
• 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 3
• 102000014128 RANK Ligand Human genes 0.000 description 3
• 108010025832 RANK Ligand Proteins 0.000 description 3
• 241000283984 Rodentia Species 0.000 description 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
• 108700028909 Serum Amyloid A Proteins 0.000 description 3
• 102000054727 Serum Amyloid A Human genes 0.000 description 3
• 108010090804 Streptavidin Proteins 0.000 description 3
• 230000006052 T cell proliferation Effects 0.000 description 3
• 108091008874 T cell receptors Proteins 0.000 description 3
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 3
• 108700009124 Transcription Initiation Site Proteins 0.000 description 3
• 150000007513 acids Chemical class 0.000 description 3
• 230000004658 acute-phase response Effects 0.000 description 3
• 238000001261 affinity purification Methods 0.000 description 3
• 238000005804 alkylation reaction Methods 0.000 description 3
• 230000007815 allergy Effects 0.000 description 3
• KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 3
• 150000001412 amines Chemical class 0.000 description 3
• 125000003277 amino group Chemical group 0.000 description 3
• 206010002022 amyloidosis Diseases 0.000 description 3
• 230000003171 anti-complementary effect Effects 0.000 description 3
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
• 230000008827 biological function Effects 0.000 description 3
• 210000001185 bone marrow Anatomy 0.000 description 3
• 238000004422 calculation algorithm Methods 0.000 description 3
• 235000014633 carbohydrates Nutrition 0.000 description 3
• 239000002738 chelating agent Substances 0.000 description 3
• 210000000349 chromosome Anatomy 0.000 description 3
• 239000013599 cloning vector Substances 0.000 description 3
• 239000003184 complementary RNA Substances 0.000 description 3
• 239000003636 conditioned culture medium Substances 0.000 description 3
• 238000007796 conventional method Methods 0.000 description 3
• 230000001086 cytosolic effect Effects 0.000 description 3
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 3
• 238000001212 derivatisation Methods 0.000 description 3
• 238000013461 design Methods 0.000 description 3
• 238000000502 dialysis Methods 0.000 description 3
• 230000029087 digestion Effects 0.000 description 3
• 208000010643 digestive system disease Diseases 0.000 description 3
• 239000003937 drug carrier Substances 0.000 description 3
• 239000003623 enhancer Substances 0.000 description 3
• 210000002950 fibroblast Anatomy 0.000 description 3
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
• 238000010353 genetic engineering Methods 0.000 description 3
• 108010055341 glutamyl-glutamic acid Proteins 0.000 description 3
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
• 208000024908 graft versus host disease Diseases 0.000 description 3
• 208000024557 hepatobiliary disease Diseases 0.000 description 3
• 102000053162 human IL17A Human genes 0.000 description 3
• 238000009396 hybridization Methods 0.000 description 3
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
• 230000001900 immune effect Effects 0.000 description 3
• 210000000987 immune system Anatomy 0.000 description 3
• 230000001976 improved effect Effects 0.000 description 3
• 230000006698 induction Effects 0.000 description 3
• 239000012678 infectious agent Substances 0.000 description 3
• 210000004969 inflammatory cell Anatomy 0.000 description 3
• 239000003112 inhibitor Substances 0.000 description 3
• 238000003780 insertion Methods 0.000 description 3
• 230000037431 insertion Effects 0.000 description 3
• 238000004255 ion exchange chromatography Methods 0.000 description 3
• 208000032839 leukemia Diseases 0.000 description 3
• 210000000265 leukocyte Anatomy 0.000 description 3
• 238000004020 luminiscence type Methods 0.000 description 3
• 239000000463 material Substances 0.000 description 3
• 230000007246 mechanism Effects 0.000 description 3
• 239000002609 medium Substances 0.000 description 3
• 229910021645 metal ion Inorganic materials 0.000 description 3
• CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 description 3
• 238000010172 mouse model Methods 0.000 description 3
• 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 3
• 238000006386 neutralization reaction Methods 0.000 description 3
• 210000001672 ovary Anatomy 0.000 description 3
• 210000000496 pancreas Anatomy 0.000 description 3
• 244000052769 pathogen Species 0.000 description 3
• 230000008506 pathogenesis Effects 0.000 description 3
• 229940111202 pepsin Drugs 0.000 description 3
• 210000001322 periplasm Anatomy 0.000 description 3
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
• 230000001817 pituitary effect Effects 0.000 description 3
• 239000013600 plasmid vector Substances 0.000 description 3
• 239000002243 precursor Substances 0.000 description 3
• 239000000376 reactant Substances 0.000 description 3
• 230000010076 replication Effects 0.000 description 3
• 108091092562 ribozyme Proteins 0.000 description 3
• 238000000926 separation method Methods 0.000 description 3
• 210000000813 small intestine Anatomy 0.000 description 3
• 239000007790 solid phase Substances 0.000 description 3
• 230000000638 stimulation Effects 0.000 description 3
• 238000001356 surgical procedure Methods 0.000 description 3
• 230000001988 toxicity Effects 0.000 description 3
• 231100000419 toxicity Toxicity 0.000 description 3
• 238000011830 transgenic mouse model Methods 0.000 description 3
• 230000004614 tumor growth Effects 0.000 description 3
• 241001529453 unidentified herpesvirus Species 0.000 description 3
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
• PDRJLZDUOULRHE-ZETCQYMHSA-N (2s)-2-amino-3-pyridin-2-ylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=N1 PDRJLZDUOULRHE-ZETCQYMHSA-N 0.000 description 2
• FQFVANSXYKWQOT-ZETCQYMHSA-N (2s)-2-azaniumyl-3-pyridin-4-ylpropanoate Chemical compound OC(=O)[C@@H](N)CC1=CC=NC=C1 FQFVANSXYKWQOT-ZETCQYMHSA-N 0.000 description 2
• 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
• 244000105975 Antidesma platyphyllum Species 0.000 description 2
• 101100437118 Arabidopsis thaliana AUG1 gene Proteins 0.000 description 2
• 101100437119 Arabidopsis thaliana AUG2 gene Proteins 0.000 description 2
• 241001203868 Autographa californica Species 0.000 description 2
• 244000063299 Bacillus subtilis Species 0.000 description 2
• 235000014469 Bacillus subtilis Nutrition 0.000 description 2
• 208000006386 Bone Resorption Diseases 0.000 description 2
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
• 108010074051 C-Reactive Protein Proteins 0.000 description 2
• 102100032752 C-reactive protein Human genes 0.000 description 2
• 108020004638 Circular DNA Proteins 0.000 description 2
• 108700010070 Codon Usage Proteins 0.000 description 2
• 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 description 2
• 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 description 2
• IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 2
• 239000003155 DNA primer Substances 0.000 description 2
• 206010012735 Diarrhoea Diseases 0.000 description 2
• AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
• 206010059866 Drug resistance Diseases 0.000 description 2
• 101150029662 E1 gene Proteins 0.000 description 2
• 102100031780 Endonuclease Human genes 0.000 description 2
• 108010075944 Erythropoietin Receptors Proteins 0.000 description 2
• 102100036509 Erythropoietin receptor Human genes 0.000 description 2
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
• 108091029865 Exogenous DNA Proteins 0.000 description 2
• 108060002716 Exonuclease Proteins 0.000 description 2
• 108010067193 Formaldehyde transketolase Proteins 0.000 description 2
• 108090000698 Formate Dehydrogenases Proteins 0.000 description 2
• 108010024636 Glutathione Proteins 0.000 description 2
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
• 108010054017 Granulocyte Colony-Stimulating Factor Receptors Proteins 0.000 description 2
• 102100039622 Granulocyte colony-stimulating factor receptor Human genes 0.000 description 2
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 2
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 2
• 101000998151 Homo sapiens Interleukin-17F Proteins 0.000 description 2
• 206010061598 Immunodeficiency Diseases 0.000 description 2
• 102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 2
• 108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 2
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 2
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 2
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 2
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 2
• 108010065805 Interleukin-12 Proteins 0.000 description 2
• 102000013462 Interleukin-12 Human genes 0.000 description 2
• 108010065637 Interleukin-23 Proteins 0.000 description 2
• 108010038452 Interleukin-3 Receptors Proteins 0.000 description 2
• 102000010790 Interleukin-3 Receptors Human genes 0.000 description 2
• 108090000978 Interleukin-4 Proteins 0.000 description 2
• 108010038501 Interleukin-6 Receptors Proteins 0.000 description 2
• 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 2
• 102000015696 Interleukins Human genes 0.000 description 2
• 108010063738 Interleukins Proteins 0.000 description 2
• 206010023203 Joint destruction Diseases 0.000 description 2
• 208000008839 Kidney Neoplasms Diseases 0.000 description 2
• 241000235058 Komagataella pastoris Species 0.000 description 2
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
• 239000005089 Luciferase Substances 0.000 description 2
• 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 2
• 108090000157 Metallothionein Proteins 0.000 description 2
• 101000998150 Mus musculus Interleukin-17F Proteins 0.000 description 2
• NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
• 238000005481 NMR spectroscopy Methods 0.000 description 2
• 229930193140 Neomycin Natural products 0.000 description 2
• PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
• 108020004485 Nonsense Codon Proteins 0.000 description 2
• 108091060545 Nonsense suppressor Proteins 0.000 description 2
• 108010067902 Peptide Library Proteins 0.000 description 2
• 102000011755 Phosphoglycerate Kinase Human genes 0.000 description 2
• 102100027330 Phosphoribosylaminoimidazole carboxylase Human genes 0.000 description 2
• 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 2
• NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
• 108010029485 Protein Isoforms Proteins 0.000 description 2
• 102000001708 Protein Isoforms Human genes 0.000 description 2
• 108010067787 Proteoglycans Proteins 0.000 description 2
• 102000016611 Proteoglycans Human genes 0.000 description 2
• 206010037660 Pyrexia Diseases 0.000 description 2
• 108010009460 RNA Polymerase II Proteins 0.000 description 2
• 102000009572 RNA Polymerase II Human genes 0.000 description 2
• 108020004511 Recombinant DNA Proteins 0.000 description 2
• 108091027981 Response element Proteins 0.000 description 2
• 102000004167 Ribonuclease P Human genes 0.000 description 2
• 108090000621 Ribonuclease P Proteins 0.000 description 2
• 238000012300 Sequence Analysis Methods 0.000 description 2
• 108700025832 Serum Response Element Proteins 0.000 description 2
• 108020004682 Single-Stranded DNA Proteins 0.000 description 2
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
• 206010041660 Splenomegaly Diseases 0.000 description 2
• 108700005078 Synthetic Genes Proteins 0.000 description 2
• 210000004241 Th2 cell Anatomy 0.000 description 2
• 101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 2
• 239000004473 Threonine Substances 0.000 description 2
• 108010022394 Threonine synthase Proteins 0.000 description 2
• 102100034196 Thrombopoietin receptor Human genes 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 2
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
• 230000002378 acidificating effect Effects 0.000 description 2
• 230000001464 adherent effect Effects 0.000 description 2
• 239000002671 adjuvant Substances 0.000 description 2
• 235000004279 alanine Nutrition 0.000 description 2
• 125000003282 alkyl amino group Chemical group 0.000 description 2
• 230000029936 alkylation Effects 0.000 description 2
• 150000001408 amides Chemical class 0.000 description 2
• 230000003321 amplification Effects 0.000 description 2
• 230000033115 angiogenesis Effects 0.000 description 2
• 230000003367 anti-collagen effect Effects 0.000 description 2
• 230000000692 anti-sense effect Effects 0.000 description 2
• 230000005875 antibody response Effects 0.000 description 2
• 239000000074 antisense oligonucleotide Substances 0.000 description 2
• 238000012230 antisense oligonucleotides Methods 0.000 description 2
• 230000001363 autoimmune Effects 0.000 description 2
• 230000005784 autoimmunity Effects 0.000 description 2
• 238000004166 bioassay Methods 0.000 description 2
• 238000010256 biochemical assay Methods 0.000 description 2
• 230000003115 biocidal effect Effects 0.000 description 2
• 230000033228 biological regulation Effects 0.000 description 2
• 230000008512 biological response Effects 0.000 description 2
• 210000004369 blood Anatomy 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• 230000017531 blood circulation Effects 0.000 description 2
• 230000024279 bone resorption Effects 0.000 description 2
• 229940098773 bovine serum albumin Drugs 0.000 description 2
• 210000004556 brain Anatomy 0.000 description 2
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
• 230000005907 cancer growth Effects 0.000 description 2
• 239000004202 carbamide Substances 0.000 description 2
• 125000000837 carbohydrate group Chemical group 0.000 description 2
• 230000015556 catabolic process Effects 0.000 description 2
• 238000004113 cell culture Methods 0.000 description 2
• 230000010261 cell growth Effects 0.000 description 2
• 210000000170 cell membrane Anatomy 0.000 description 2
• 230000004663 cell proliferation Effects 0.000 description 2
• 238000001516 cell proliferation assay Methods 0.000 description 2
• 230000036755 cellular response Effects 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 238000012512 characterization method Methods 0.000 description 2
• 238000007385 chemical modification Methods 0.000 description 2
• 239000007795 chemical reaction product Substances 0.000 description 2
• 239000003795 chemical substances by application Substances 0.000 description 2
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
• 239000012501 chromatography medium Substances 0.000 description 2
• PMMYEEVYMWASQN-IMJSIDKUSA-N cis-4-Hydroxy-L-proline Chemical compound O[C@@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-IMJSIDKUSA-N 0.000 description 2
• 208000029742 colonic neoplasm Diseases 0.000 description 2
• 230000024203 complement activation Effects 0.000 description 2
• 210000002808 connective tissue Anatomy 0.000 description 2
• 238000010276 construction Methods 0.000 description 2
• 230000000139 costimulatory effect Effects 0.000 description 2
• 239000013078 crystal Substances 0.000 description 2
• 210000004748 cultured cell Anatomy 0.000 description 2
• 229940095074 cyclic amp Drugs 0.000 description 2
• 230000007123 defense Effects 0.000 description 2
• 238000006731 degradation reaction Methods 0.000 description 2
• 230000001419 dependent effect Effects 0.000 description 2
• 102000004419 dihydrofolate reductase Human genes 0.000 description 2
• XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 2
• 229960002986 dinoprostone Drugs 0.000 description 2
• 238000009826 distribution Methods 0.000 description 2
• PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
• 238000010828 elution Methods 0.000 description 2
• 102000013165 exonuclease Human genes 0.000 description 2
• 239000000284 extract Substances 0.000 description 2
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
• 239000007850 fluorescent dye Substances 0.000 description 2
• 238000005194 fractionation Methods 0.000 description 2
• 230000002538 fungal effect Effects 0.000 description 2
• 239000000499 gel Substances 0.000 description 2
• 229910052737 gold Inorganic materials 0.000 description 2
• 239000010931 gold Substances 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 235000009424 haa Nutrition 0.000 description 2
• 210000002216 heart Anatomy 0.000 description 2
• 108010044853 histidine-rich proteins Proteins 0.000 description 2
• 238000002744 homologous recombination Methods 0.000 description 2
• 230000006801 homologous recombination Effects 0.000 description 2
• 102000056946 human IL17F Human genes 0.000 description 2
• 229910052739 hydrogen Inorganic materials 0.000 description 2
• 230000007062 hydrolysis Effects 0.000 description 2
• 238000006460 hydrolysis reaction Methods 0.000 description 2
• 230000003463 hyperproliferative effect Effects 0.000 description 2
• 230000005847 immunogenicity Effects 0.000 description 2
• 230000016784 immunoglobulin production Effects 0.000 description 2
• 239000002955 immunomodulating agent Substances 0.000 description 2
• 229940121354 immunomodulator Drugs 0.000 description 2
• 238000000099 in vitro assay Methods 0.000 description 2
• 239000000411 inducer Substances 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 230000010354 integration Effects 0.000 description 2
• 230000004068 intracellular signaling Effects 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 238000002372 labelling Methods 0.000 description 2
• 101150066555 lacZ gene Proteins 0.000 description 2
• 210000002429 large intestine Anatomy 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 210000005228 liver tissue Anatomy 0.000 description 2
• 210000001165 lymph node Anatomy 0.000 description 2
• 238000013507 mapping Methods 0.000 description 2
• 230000035800 maturation Effects 0.000 description 2
• 210000003071 memory t lymphocyte Anatomy 0.000 description 2
• 230000002503 metabolic effect Effects 0.000 description 2
• 238000007799 mixed lymphocyte reaction assay Methods 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 206010028417 myasthenia gravis Diseases 0.000 description 2
• 229960004927 neomycin Drugs 0.000 description 2
• 230000001537 neural effect Effects 0.000 description 2
• 230000037434 nonsense mutation Effects 0.000 description 2
• 238000003199 nucleic acid amplification method Methods 0.000 description 2
• 210000003463 organelle Anatomy 0.000 description 2
• 230000002018 overexpression Effects 0.000 description 2
• 210000005259 peripheral blood Anatomy 0.000 description 2
• 239000011886 peripheral blood Substances 0.000 description 2
• 239000008194 pharmaceutical composition Substances 0.000 description 2
• 108010035774 phosphoribosylaminoimidazole carboxylase Proteins 0.000 description 2
• 238000005222 photoaffinity labeling Methods 0.000 description 2
• 210000002826 placenta Anatomy 0.000 description 2
• 229920002401 polyacrylamide Polymers 0.000 description 2
• 229940124606 potential therapeutic agent Drugs 0.000 description 2
• XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 2
• 210000002307 prostate Anatomy 0.000 description 2
• 238000001742 protein purification Methods 0.000 description 2
• 150000003212 purines Chemical class 0.000 description 2
• RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 2
• 150000003230 pyrimidines Chemical class 0.000 description 2
• 238000002708 random mutagenesis Methods 0.000 description 2
• 230000009257 reactivity Effects 0.000 description 2
• 229940044551 receptor antagonist Drugs 0.000 description 2
• 239000002464 receptor antagonist Substances 0.000 description 2
• 230000008085 renal dysfunction Effects 0.000 description 2
• FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
• 238000013391 scatchard analysis Methods 0.000 description 2
• 230000035939 shock Effects 0.000 description 2
• 239000000377 silicon dioxide Substances 0.000 description 2
• 238000001542 size-exclusion chromatography Methods 0.000 description 2
• 210000002027 skeletal muscle Anatomy 0.000 description 2
• 210000003491 skin Anatomy 0.000 description 2
• 238000010532 solid phase synthesis reaction Methods 0.000 description 2
• 230000009870 specific binding Effects 0.000 description 2
• 210000000278 spinal cord Anatomy 0.000 description 2
• 210000000130 stem cell Anatomy 0.000 description 2
• 230000004936 stimulating effect Effects 0.000 description 2
• 210000002784 stomach Anatomy 0.000 description 2
• 125000001424 substituent group Chemical group 0.000 description 2
• 229910052717 sulfur Inorganic materials 0.000 description 2
• 239000011593 sulfur Substances 0.000 description 2
• 230000001629 suppression Effects 0.000 description 2
• 208000011580 syndromic disease Diseases 0.000 description 2
• 230000008409 synovial inflammation Effects 0.000 description 2
• 230000002194 synthesizing effect Effects 0.000 description 2
• 230000009885 systemic effect Effects 0.000 description 2
• 210000001550 testis Anatomy 0.000 description 2
• 210000001541 thymus gland Anatomy 0.000 description 2
• 210000001685 thyroid gland Anatomy 0.000 description 2
• 230000000451 tissue damage Effects 0.000 description 2
• 231100000827 tissue damage Toxicity 0.000 description 2
• 210000005092 tracheal tissue Anatomy 0.000 description 2
• 230000005026 transcription initiation Effects 0.000 description 2
• 238000001890 transfection Methods 0.000 description 2
• 230000009466 transformation Effects 0.000 description 2
• 230000007704 transition Effects 0.000 description 2
• 230000032258 transport Effects 0.000 description 2
• 230000008733 trauma Effects 0.000 description 2
• 229910052721 tungsten Inorganic materials 0.000 description 2
• 241001515965 unidentified phage Species 0.000 description 2
• 238000001262 western blot Methods 0.000 description 2
• 229910052727 yttrium Inorganic materials 0.000 description 2
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
• VZQHRKZCAZCACO-PYJNHQTQSA-N (2s)-2-[[(2s)-2-[2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]prop-2-enoylamino]-3-methylbutanoyl]amino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VZQHRKZCAZCACO-PYJNHQTQSA-N 0.000 description 1
• DFZVZEMNPGABKO-ZETCQYMHSA-N (2s)-2-amino-3-pyridin-3-ylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CN=C1 DFZVZEMNPGABKO-ZETCQYMHSA-N 0.000 description 1
• JQFLYFRHDIHZFZ-RXMQYKEDSA-N (2s)-3,3-dimethylpyrrolidine-2-carboxylic acid Chemical compound CC1(C)CCN[C@@H]1C(O)=O JQFLYFRHDIHZFZ-RXMQYKEDSA-N 0.000 description 1
• CNPSFBUUYIVHAP-AKGZTFGVSA-N (2s)-3-methylpyrrolidine-2-carboxylic acid Chemical compound CC1CCN[C@@H]1C(O)=O CNPSFBUUYIVHAP-AKGZTFGVSA-N 0.000 description 1
• FXGZFWDCXQRZKI-VKHMYHEASA-N (2s)-5-amino-2-nitramido-5-oxopentanoic acid Chemical compound NC(=O)CC[C@@H](C(O)=O)N[N+]([O-])=O FXGZFWDCXQRZKI-VKHMYHEASA-N 0.000 description 1
• JPOKAKNGULMYHZ-UILVTTEASA-N (2s)-6-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-6-amino-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]hexanoyl]amino]-3-(4-hydroxyp Chemical compound C([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N)C1=CC=C(O)C=C1 JPOKAKNGULMYHZ-UILVTTEASA-N 0.000 description 1
• CCAIIPMIAFGKSI-DMTCNVIQSA-N (2s,3r)-3-hydroxy-2-(methylazaniumyl)butanoate Chemical compound CN[C@@H]([C@@H](C)O)C(O)=O CCAIIPMIAFGKSI-DMTCNVIQSA-N 0.000 description 1
• CNPSFBUUYIVHAP-WHFBIAKZSA-N (2s,3s)-3-methylpyrrolidin-1-ium-2-carboxylate Chemical compound C[C@H]1CCN[C@@H]1C(O)=O CNPSFBUUYIVHAP-WHFBIAKZSA-N 0.000 description 1
• 125000000027 (C1-C10) alkoxy group Chemical group 0.000 description 1
• GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
• PNDPGZBMCMUPRI-HVTJNCQCSA-N 10043-66-0 Chemical compound [131I][131I] PNDPGZBMCMUPRI-HVTJNCQCSA-N 0.000 description 1
• WUAPFZMCVAUBPE-NJFSPNSNSA-N 188Re Chemical compound [188Re] WUAPFZMCVAUBPE-NJFSPNSNSA-N 0.000 description 1
• 102000007445 2',5'-Oligoadenylate Synthetase Human genes 0.000 description 1
• 108010086241 2',5'-Oligoadenylate Synthetase Proteins 0.000 description 1
• OMGHIGVFLOPEHJ-UHFFFAOYSA-N 2,5-dihydro-1h-pyrrol-1-ium-2-carboxylate Chemical compound OC(=O)C1NCC=C1 OMGHIGVFLOPEHJ-UHFFFAOYSA-N 0.000 description 1
• MUSGYEMSJUFFHT-UWABRSFTSA-N 2-[(4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-34-[[(2S,3S)-2-[[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-4-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]-methylcarbamoyl]-25-(3-amino-3-oxopropyl)-7-(3-carbamimidamidopropyl)-10-(1H-imidazol-5-ylmethyl)-19-(1H-indol-3-ylmethyl)-13,17-dimethyl-28-[(1-methylindol-3-yl)methyl]-6,9,12,15,18,21,24,27,30,33-decaoxo-31-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decazacyclopentatriacont-22-yl]acetic acid Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](N)Cc1ccc(O)cc1)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](C)NC(=O)CN(C)C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cn(C)c3ccccc23)NC(=O)[C@@H](NC1=O)C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)C(N)=O MUSGYEMSJUFFHT-UWABRSFTSA-N 0.000 description 1
• KZMAWJRXKGLWGS-UHFFFAOYSA-N 2-chloro-n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-n-(3-methoxypropyl)acetamide Chemical compound S1C(N(C(=O)CCl)CCCOC)=NC(C=2C=CC(OC)=CC=2)=C1 KZMAWJRXKGLWGS-UHFFFAOYSA-N 0.000 description 1
• BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical class CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
• XEVFXAFXZZYFSX-UHFFFAOYSA-N 3-azabicyclo[2.1.1]hexane-4-carboxylic acid Chemical compound C1C2CC1(C(=O)O)NC2 XEVFXAFXZZYFSX-UHFFFAOYSA-N 0.000 description 1
• 125000000972 4,5-dimethylthiazol-2-yl group Chemical group [H]C([H])([H])C1=C(N=C(*)S1)C([H])([H])[H] 0.000 description 1
• 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 1
• HUDPLKWXRLNSPC-UHFFFAOYSA-N 4-aminophthalhydrazide Chemical compound O=C1NNC(=O)C=2C1=CC(N)=CC=2 HUDPLKWXRLNSPC-UHFFFAOYSA-N 0.000 description 1
• XWHHYOYVRVGJJY-QMMMGPOBSA-N 4-fluoro-L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(F)C=C1 XWHHYOYVRVGJJY-QMMMGPOBSA-N 0.000 description 1
• FVFVNNKYKYZTJU-UHFFFAOYSA-N 6-chloro-1,3,5-triazine-2,4-diamine Chemical group NC1=NC(N)=NC(Cl)=N1 FVFVNNKYKYZTJU-UHFFFAOYSA-N 0.000 description 1
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical group N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
• 101150096273 ADE2 gene Proteins 0.000 description 1
• 206010060921 Abdominal abscess Diseases 0.000 description 1
• 108010066676 Abrin Proteins 0.000 description 1
• 102000013563 Acid Phosphatase Human genes 0.000 description 1
• 108010051457 Acid Phosphatase Proteins 0.000 description 1
• 241000228431 Acremonium chrysogenum Species 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 108010062271 Acute-Phase Proteins Proteins 0.000 description 1
• 102000011767 Acute-Phase Proteins Human genes 0.000 description 1
• 229930024421 Adenine Natural products 0.000 description 1
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
• 108010000239 Aequorin Proteins 0.000 description 1
• 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
• 108010025188 Alcohol oxidase Proteins 0.000 description 1
• 102100036826 Aldehyde oxidase Human genes 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 102100024321 Alkaline phosphatase, placental type Human genes 0.000 description 1
• 108700028369 Alleles Proteins 0.000 description 1
• 229920000856 Amylose Polymers 0.000 description 1
• 208000031295 Animal disease Diseases 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 241000228212 Aspergillus Species 0.000 description 1
• 241000271566 Aves Species 0.000 description 1
• 102000005738 B7 Antigens Human genes 0.000 description 1
• 108010045634 B7 Antigens Proteins 0.000 description 1
• 201000001178 Bacterial Pneumonia Diseases 0.000 description 1
• 108010077805 Bacterial Proteins Proteins 0.000 description 1
• 231100000699 Bacterial toxin Toxicity 0.000 description 1
• 108700027842 Bacteriophage lambda DNA replication complex Proteins 0.000 description 1
• 108700040077 Baculovirus p10 Proteins 0.000 description 1
• 208000023328 Basedow disease Diseases 0.000 description 1
• 102100029516 Basic salivary proline-rich protein 1 Human genes 0.000 description 1
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• 235000018185 Betula X alpestris Nutrition 0.000 description 1
• 235000018212 Betula X uliginosa Nutrition 0.000 description 1
• 241000212384 Bifora Species 0.000 description 1
• 206010051728 Bone erosion Diseases 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 241000701822 Bovine papillomavirus Species 0.000 description 1
• 206010006458 Bronchitis chronic Diseases 0.000 description 1
• 102100021943 C-C motif chemokine 2 Human genes 0.000 description 1
• 101710155857 C-C motif chemokine 2 Proteins 0.000 description 1
• 102100021935 C-C motif chemokine 26 Human genes 0.000 description 1
• 102100025248 C-X-C motif chemokine 10 Human genes 0.000 description 1
• 101710098275 C-X-C motif chemokine 10 Proteins 0.000 description 1
• 102100036170 C-X-C motif chemokine 9 Human genes 0.000 description 1
• 101710085500 C-X-C motif chemokine 9 Proteins 0.000 description 1
• OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 1
• 108010021064 CTLA-4 Antigen Proteins 0.000 description 1
• 229940045513 CTLA4 antagonist Drugs 0.000 description 1
• 102000000584 Calmodulin Human genes 0.000 description 1
• 108010041952 Calmodulin Proteins 0.000 description 1
• 241000222128 Candida maltosa Species 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• 241000282461 Canis lupus Species 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 108010078791 Carrier Proteins Proteins 0.000 description 1
• 208000005024 Castleman disease Diseases 0.000 description 1
• 241000700198 Cavia Species 0.000 description 1
• 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
• 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 102000019034 Chemokines Human genes 0.000 description 1
• 108010012236 Chemokines Proteins 0.000 description 1
• 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
• 241000282552 Chlorocebus aethiops Species 0.000 description 1
• 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
• 108010005939 Ciliary Neurotrophic Factor Proteins 0.000 description 1
• 102100031614 Ciliary neurotrophic factor Human genes 0.000 description 1
• 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
• 101100007328 Cocos nucifera COS-1 gene Proteins 0.000 description 1
• 102000000503 Collagen Type II Human genes 0.000 description 1
• 108010041390 Collagen Type II Proteins 0.000 description 1
• 102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
• 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
• 108010062580 Concanavalin A Proteins 0.000 description 1
• 206010010356 Congenital anomaly Diseases 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• 241000701022 Cytomegalovirus Species 0.000 description 1
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 1
• IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
• 241000450599 DNA viruses Species 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 201000004624 Dermatitis Diseases 0.000 description 1
• 206010012442 Dermatitis contact Diseases 0.000 description 1
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
• 102000016607 Diphtheria Toxin Human genes 0.000 description 1
• 108010053187 Diphtheria Toxin Proteins 0.000 description 1
• 206010013554 Diverticulum Diseases 0.000 description 1
• 102000001301 EGF receptor Human genes 0.000 description 1
• 108060006698 EGF receptor Proteins 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• 108010042407 Endonucleases Proteins 0.000 description 1
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 241000701959 Escherichia virus Lambda Species 0.000 description 1
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
• 241000206602 Eukaryota Species 0.000 description 1
• XZWYTXMRWQJBGX-VXBMVYAYSA-N FLAG peptide Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 XZWYTXMRWQJBGX-VXBMVYAYSA-N 0.000 description 1
• 108010020195 FLAG peptide Proteins 0.000 description 1
• 108010023321 Factor VII Proteins 0.000 description 1
• 102000002090 Fibronectin type III Human genes 0.000 description 1
• 108050009401 Fibronectin type III Proteins 0.000 description 1
• BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
• 101150094690 GAL1 gene Proteins 0.000 description 1
• 102100028501 Galanin peptides Human genes 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
• 206010018364 Glomerulonephritis Diseases 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 239000004366 Glucose oxidase Substances 0.000 description 1
• 108010015776 Glucose oxidase Proteins 0.000 description 1
• 102000000340 Glucosyltransferases Human genes 0.000 description 1
• 108010055629 Glucosyltransferases Proteins 0.000 description 1
• SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
• 108010053070 Glutathione Disulfide Proteins 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 229920002683 Glycosaminoglycan Polymers 0.000 description 1
• 208000015023 Graves' disease Diseases 0.000 description 1
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
• 102000009465 Growth Factor Receptors Human genes 0.000 description 1
• 108010009202 Growth Factor Receptors Proteins 0.000 description 1
• 108010051696 Growth Hormone Proteins 0.000 description 1
• 101150069554 HIS4 gene Proteins 0.000 description 1
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
• 206010019375 Helicobacter infections Diseases 0.000 description 1
• 102100027685 Hemoglobin subunit alpha Human genes 0.000 description 1
• 108091005902 Hemoglobin subunit alpha Proteins 0.000 description 1
• 102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
• 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
• 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 1
• 108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 1
• 101000928314 Homo sapiens Aldehyde oxidase Proteins 0.000 description 1
• 101001125486 Homo sapiens Basic salivary proline-rich protein 1 Proteins 0.000 description 1
• 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 description 1
• 101100121078 Homo sapiens GAL gene Proteins 0.000 description 1
• 101000599048 Homo sapiens Interleukin-6 receptor subunit alpha Proteins 0.000 description 1
• 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 1
• 101000741885 Homo sapiens Protection of telomeres protein 1 Proteins 0.000 description 1
• 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 description 1
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 1
• 101000799466 Homo sapiens Thrombopoietin receptor Proteins 0.000 description 1
• YZJSUQQZGCHHNQ-UHFFFAOYSA-N Homoglutamine Chemical compound OC(=O)C(N)CCCC(N)=O YZJSUQQZGCHHNQ-UHFFFAOYSA-N 0.000 description 1
• 102000003839 Human Proteins Human genes 0.000 description 1
• 108090000144 Human Proteins Proteins 0.000 description 1
• PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
• 208000001953 Hypotension Diseases 0.000 description 1
• XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
• 102000039989 IL-17 family Human genes 0.000 description 1
• 108091069193 IL-17 family Proteins 0.000 description 1
• 235000003332 Ilex aquifolium Nutrition 0.000 description 1
• 241000209027 Ilex aquifolium Species 0.000 description 1
• 208000029462 Immunodeficiency disease Diseases 0.000 description 1
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
• 206010062016 Immunosuppression Diseases 0.000 description 1
• 108010060231 Insect Proteins Proteins 0.000 description 1
• 102100022339 Integrin alpha-L Human genes 0.000 description 1
• 108010008212 Integrin alpha4beta1 Proteins 0.000 description 1
• 102100037850 Interferon gamma Human genes 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 102000019223 Interleukin-1 receptor Human genes 0.000 description 1
• 108050006617 Interleukin-1 receptor Proteins 0.000 description 1
• 102000003814 Interleukin-10 Human genes 0.000 description 1
• 108090000174 Interleukin-10 Proteins 0.000 description 1
• 102100020793 Interleukin-13 receptor subunit alpha-2 Human genes 0.000 description 1
• 102100033101 Interleukin-17B Human genes 0.000 description 1
• 108010038486 Interleukin-4 Receptors Proteins 0.000 description 1
• 102000010787 Interleukin-4 Receptors Human genes 0.000 description 1
• 108010038484 Interleukin-5 Receptors Proteins 0.000 description 1
• 102000010786 Interleukin-5 Receptors Human genes 0.000 description 1
• 102000010781 Interleukin-6 Receptors Human genes 0.000 description 1
• 108010038498 Interleukin-7 Receptors Proteins 0.000 description 1
• 102000010782 Interleukin-7 Receptors Human genes 0.000 description 1
• 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
• 208000011200 Kawasaki disease Diseases 0.000 description 1
• 244000285963 Kluyveromyces fragilis Species 0.000 description 1
• 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
• 241001138401 Kluyveromyces lactis Species 0.000 description 1
• SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
• SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
• HXEACLLIILLPRG-YFKPBYRVSA-N L-pipecolic acid Chemical compound [O-]C(=O)[C@@H]1CCCC[NH2+]1 HXEACLLIILLPRG-YFKPBYRVSA-N 0.000 description 1
• DZLNHFMRPBPULJ-VKHMYHEASA-N L-thioproline Chemical compound OC(=O)[C@@H]1CSCN1 DZLNHFMRPBPULJ-VKHMYHEASA-N 0.000 description 1
• KKJQZEWNZXRJFG-UHFFFAOYSA-N L-trans-4-Methyl-2-pyrrolidinecarboxylic acid Chemical compound CC1CNC(C(O)=O)C1 KKJQZEWNZXRJFG-UHFFFAOYSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
• 108010047357 Luminescent Proteins Proteins 0.000 description 1
• 102000006830 Luminescent Proteins Human genes 0.000 description 1
• 208000004852 Lung Injury Diseases 0.000 description 1
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 1
• 102000008072 Lymphokines Human genes 0.000 description 1
• 108010074338 Lymphokines Proteins 0.000 description 1
• 108091054455 MAP kinase family Proteins 0.000 description 1
• 102000043136 MAP kinase family Human genes 0.000 description 1
• 101710141347 Major envelope glycoprotein Proteins 0.000 description 1
• 108700020482 Maltose-Binding protein Proteins 0.000 description 1
• 108010038049 Mating Factor Proteins 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 241000713333 Mouse mammary tumor virus Species 0.000 description 1
• 108700005084 Multigene Family Proteins 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 101000969137 Mus musculus Metallothionein-1 Proteins 0.000 description 1
• 101000974353 Mus musculus Nuclear receptor coactivator 5 Proteins 0.000 description 1
• 101100243377 Mus musculus Pepd gene Proteins 0.000 description 1
• 208000007101 Muscle Cramp Diseases 0.000 description 1
• 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
• 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
• 102100030856 Myoglobin Human genes 0.000 description 1
• 108010062374 Myoglobin Proteins 0.000 description 1
• 102000003505 Myosin Human genes 0.000 description 1
• 108060008487 Myosin Proteins 0.000 description 1
• 125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
• 102000003945 NF-kappa B Human genes 0.000 description 1
• 108010014632 NF-kappa B kinase Proteins 0.000 description 1
• 206010029164 Nephrotic syndrome Diseases 0.000 description 1
• 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 1
• 241000221960 Neurospora Species 0.000 description 1
• 108091092724 Noncoding DNA Proteins 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 108091005461 Nucleic proteins Proteins 0.000 description 1
• 241000320412 Ogataea angusta Species 0.000 description 1
• 108700026244 Open Reading Frames Proteins 0.000 description 1
• 208000001388 Opportunistic Infections Diseases 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 102000016979 Other receptors Human genes 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 206010061535 Ovarian neoplasm Diseases 0.000 description 1
• 229920001734 PEG propionaldehyde Polymers 0.000 description 1
• 101150029183 PEP4 gene Proteins 0.000 description 1
• 101150012394 PHO5 gene Proteins 0.000 description 1
• 108090000526 Papain Proteins 0.000 description 1
• 241000282520 Papio Species 0.000 description 1
• 208000031481 Pathologic Constriction Diseases 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 101710176384 Peptide 1 Proteins 0.000 description 1
• 108091093037 Peptide nucleic acid Proteins 0.000 description 1
• 102000003992 Peroxidases Human genes 0.000 description 1
• 108010053210 Phycocyanin Proteins 0.000 description 1
• 241000235648 Pichia Species 0.000 description 1
• 231100000742 Plant toxin Toxicity 0.000 description 1
• 206010035226 Plasma cell myeloma Diseases 0.000 description 1
• 239000004952 Polyamide Substances 0.000 description 1
• 101710182846 Polyhedrin Proteins 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• 239000004372 Polyvinyl alcohol Substances 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 102100038745 Protection of telomeres protein 1 Human genes 0.000 description 1
• 102000012515 Protein kinase domains Human genes 0.000 description 1
• 108050002122 Protein kinase domains Proteins 0.000 description 1
• 101000762949 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) Exotoxin A Proteins 0.000 description 1
• 101100084022 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) lapA gene Proteins 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 230000006819 RNA synthesis Effects 0.000 description 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
• 206010038372 Renal arteriosclerosis Diseases 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 208000006265 Renal cell carcinoma Diseases 0.000 description 1
• 108010039491 Ricin Proteins 0.000 description 1
• 241000714474 Rous sarcoma virus Species 0.000 description 1
• 101150014136 SUC2 gene Proteins 0.000 description 1
• 241000701062 Saimiriine gammaherpesvirus 2 Species 0.000 description 1
• 108010077895 Sarcosine Proteins 0.000 description 1
• 239000002262 Schiff base Substances 0.000 description 1
• 150000004753 Schiff bases Chemical class 0.000 description 1
• 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
• 102100038803 Somatotropin Human genes 0.000 description 1
• 208000005392 Spasm Diseases 0.000 description 1
• 241000256251 Spodoptera frugiperda Species 0.000 description 1
• 241000187747 Streptomyces Species 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• 201000009594 Systemic Scleroderma Diseases 0.000 description 1
• 206010042953 Systemic sclerosis Diseases 0.000 description 1
• 230000005867 T cell response Effects 0.000 description 1
• 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 1
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 1
• 108700026226 TATA Box Proteins 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• 210000000447 Th1 cell Anatomy 0.000 description 1
• 108010070774 Thrombopoietin Receptors Proteins 0.000 description 1
• 108090000253 Thyrotropin Receptors Proteins 0.000 description 1
• 102100029337 Thyrotropin receptor Human genes 0.000 description 1
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
• 102100033571 Tissue-type plasminogen activator Human genes 0.000 description 1
• 108050006955 Tissue-type plasminogen activator Proteins 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
• 206010052779 Transplant rejections Diseases 0.000 description 1
• 206010069363 Traumatic lung injury Diseases 0.000 description 1
• 241000255993 Trichoplusia ni Species 0.000 description 1
• YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 1
• 208000025865 Ulcer Diseases 0.000 description 1
• 244000274883 Urtica dioica Species 0.000 description 1
• 235000009108 Urtica dioica Nutrition 0.000 description 1
• 241000221566 Ustilago Species 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 241000700618 Vaccinia virus Species 0.000 description 1
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
• 108020005202 Viral DNA Proteins 0.000 description 1
• 241000269370 Xenopus <genus> Species 0.000 description 1
• VWQVUPCCIRVNHF-OUBTZVSYSA-N Yttrium-90 Chemical compound [90Y] VWQVUPCCIRVNHF-OUBTZVSYSA-N 0.000 description 1
• PCBMGUSDYHYVBQ-SOOFDHNKSA-N [4-amino-2-[(3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-imidazol-5-yl]phosphonic acid Chemical compound P(=O)(O)(O)C=1N=C(NC1N)C1[C@H](O)[C@H](O)[C@H](O1)CO PCBMGUSDYHYVBQ-SOOFDHNKSA-N 0.000 description 1
• 230000003187 abdominal effect Effects 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 108020002494 acetyltransferase Proteins 0.000 description 1
• 102000005421 acetyltransferase Human genes 0.000 description 1
• DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical class C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 208000038016 acute inflammation Diseases 0.000 description 1
• 230000006022 acute inflammation Effects 0.000 description 1
• 125000002252 acyl group Chemical group 0.000 description 1
• 239000000654 additive Substances 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 229960000643 adenine Drugs 0.000 description 1
• 230000001919 adrenal effect Effects 0.000 description 1
• 210000004100 adrenal gland Anatomy 0.000 description 1
• 229940009456 adriamycin Drugs 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 230000001270 agonistic effect Effects 0.000 description 1
• 238000012867 alanine scanning Methods 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 239000013566 allergen Substances 0.000 description 1
• 201000009961 allergic asthma Diseases 0.000 description 1
• 108010004469 allophycocyanin Proteins 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 229940037003 alum Drugs 0.000 description 1
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
• ROLZYTOAMYXLMF-UHFFFAOYSA-N amino(benzyl)carbamic acid Chemical compound OC(=O)N(N)CC1=CC=CC=C1 ROLZYTOAMYXLMF-UHFFFAOYSA-N 0.000 description 1
• 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
• 229960000723 ampicillin Drugs 0.000 description 1
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
• 238000004873 anchoring Methods 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 210000000628 antibody-producing cell Anatomy 0.000 description 1
• 102000025171 antigen binding proteins Human genes 0.000 description 1
• 108091000831 antigen binding proteins Proteins 0.000 description 1
• 230000005775 apoptotic pathway Effects 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 210000001188 articular cartilage Anatomy 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 125000004104 aryloxy group Chemical group 0.000 description 1
• 229920001718 aryloxy-PEG Polymers 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229940009098 aspartate Drugs 0.000 description 1
• 238000002820 assay format Methods 0.000 description 1
• 238000003149 assay kit Methods 0.000 description 1
• 208000010668 atopic eczema Diseases 0.000 description 1
• 230000006472 autoimmune response Effects 0.000 description 1
• 238000000376 autoradiography Methods 0.000 description 1
• IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
• 239000000688 bacterial toxin Substances 0.000 description 1
• 108010028263 bacteriophage T3 RNA polymerase Proteins 0.000 description 1
• 239000002585 base Substances 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
• 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
• 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
• 108010005774 beta-Galactosidase Proteins 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 230000000975 bioactive effect Effects 0.000 description 1
• 230000008236 biological pathway Effects 0.000 description 1
• 239000012472 biological sample Substances 0.000 description 1
• 230000029918 bioluminescence Effects 0.000 description 1
• 238000005415 bioluminescence Methods 0.000 description 1
• 229920001743 bis-succinimidyl carbonate PEG Polymers 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 238000010322 bone marrow transplantation Methods 0.000 description 1
• 230000004097 bone metabolism Effects 0.000 description 1
• WVMHLYQJPRXKLC-UHFFFAOYSA-N borane;n,n-dimethylmethanamine Chemical compound B.CN(C)C WVMHLYQJPRXKLC-UHFFFAOYSA-N 0.000 description 1
• 150000001639 boron compounds Chemical class 0.000 description 1
• RJTANRZEWTUVMA-UHFFFAOYSA-N boron;n-methylmethanamine Chemical compound [B].CNC RJTANRZEWTUVMA-UHFFFAOYSA-N 0.000 description 1
• NNTOJPXOCKCMKR-UHFFFAOYSA-N boron;pyridine Chemical compound [B].C1=CC=NC=C1 NNTOJPXOCKCMKR-UHFFFAOYSA-N 0.000 description 1
• 206010006451 bronchitis Diseases 0.000 description 1
• 239000007853 buffer solution Substances 0.000 description 1
• 239000007975 buffered saline Substances 0.000 description 1
• 244000309464 bull Species 0.000 description 1
• ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 102000028861 calmodulin binding Human genes 0.000 description 1
• 108091000084 calmodulin binding Proteins 0.000 description 1
• 238000007816 calorimetric assay Methods 0.000 description 1
• 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
• 125000002837 carbocyclic group Chemical group 0.000 description 1
• 150000001718 carbodiimides Chemical class 0.000 description 1
• 230000021164 cell adhesion Effects 0.000 description 1
• 238000000423 cell based assay Methods 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 230000022131 cell cycle Effects 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 230000006037 cell lysis Effects 0.000 description 1
• 210000002421 cell wall Anatomy 0.000 description 1
• 210000004671 cell-free system Anatomy 0.000 description 1
• 230000019522 cellular metabolic process Effects 0.000 description 1
• 239000012461 cellulose resin Substances 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 239000013522 chelant Substances 0.000 description 1
• 229920001429 chelating resin Polymers 0.000 description 1
• 238000001311 chemical methods and process Methods 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 230000035605 chemotaxis Effects 0.000 description 1
• 235000013330 chicken meat Nutrition 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 208000007451 chronic bronchitis Diseases 0.000 description 1
• 230000006020 chronic inflammation Effects 0.000 description 1
• 235000017803 cinnamon Nutrition 0.000 description 1
• 238000003501 co-culture Methods 0.000 description 1
• 229940047120 colony stimulating factors Drugs 0.000 description 1
• 238000007398 colorimetric assay Methods 0.000 description 1
• 238000012875 competitive assay Methods 0.000 description 1
• 230000002860 competitive effect Effects 0.000 description 1
• 238000009833 condensation Methods 0.000 description 1
• 230000005494 condensation Effects 0.000 description 1
• 208000010247 contact dermatitis Diseases 0.000 description 1
• NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
• 229920001577 copolymer Polymers 0.000 description 1
• 235000005687 corn oil Nutrition 0.000 description 1
• 239000002285 corn oil Substances 0.000 description 1
• 238000012258 culturing Methods 0.000 description 1
• ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
• 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 239000002254 cytotoxic agent Substances 0.000 description 1
• 229940127089 cytotoxic agent Drugs 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 239000003398 denaturant Substances 0.000 description 1
• 210000004443 dendritic cell Anatomy 0.000 description 1
• 230000030609 dephosphorylation Effects 0.000 description 1
• 238000006209 dephosphorylation reaction Methods 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 230000018109 developmental process Effects 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 238000002405 diagnostic procedure Methods 0.000 description 1
• PGUYAANYCROBRT-UHFFFAOYSA-N dihydroxy-selanyl-selanylidene-lambda5-phosphane Chemical compound OP(O)([SeH])=[Se] PGUYAANYCROBRT-UHFFFAOYSA-N 0.000 description 1
• 238000007865 diluting Methods 0.000 description 1
• 239000000539 dimer Substances 0.000 description 1
• 238000006471 dimerization reaction Methods 0.000 description 1
• NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
• 231100000676 disease causative agent Toxicity 0.000 description 1
• 208000035475 disorder Diseases 0.000 description 1
• 208000009190 disseminated intravascular coagulation Diseases 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• 125000002228 disulfide group Chemical group 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 150000002061 ecdysteroids Chemical class 0.000 description 1
• 230000005684 electric field Effects 0.000 description 1
• 210000002308 embryonic cell Anatomy 0.000 description 1
• 210000001671 embryonic stem cell Anatomy 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 230000006862 enzymatic digestion Effects 0.000 description 1
• 230000002327 eosinophilic effect Effects 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 239000003797 essential amino acid Substances 0.000 description 1
• 235000020776 essential amino acid Nutrition 0.000 description 1
• 150000002170 ethers Chemical class 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 108010092809 exonuclease Bal 31 Proteins 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 238000001400 expression cloning Methods 0.000 description 1
• 102000036444 extracellular matrix enzymes Human genes 0.000 description 1
• 108091007167 extracellular matrix enzymes Proteins 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 230000000893 fibroproliferative effect Effects 0.000 description 1
• ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 1
• 238000001215 fluorescent labelling Methods 0.000 description 1
• 230000004907 flux Effects 0.000 description 1
• 210000002683 foot Anatomy 0.000 description 1
• 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
• 238000013467 fragmentation Methods 0.000 description 1
• 238000006062 fragmentation reaction Methods 0.000 description 1
• 238000010230 functional analysis Methods 0.000 description 1
• 238000004362 fungal culture Methods 0.000 description 1
• 229930182830 galactose Natural products 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 230000004545 gene duplication Effects 0.000 description 1
• 102000054767 gene variant Human genes 0.000 description 1
• 208000007565 gingivitis Diseases 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 206010061989 glomerulosclerosis Diseases 0.000 description 1
• 239000003862 glucocorticoid Substances 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 229940116332 glucose oxidase Drugs 0.000 description 1
• 235000019420 glucose oxidase Nutrition 0.000 description 1
• 108010046301 glucose peroxidase Proteins 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 229960003180 glutathione Drugs 0.000 description 1
• YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 1
• 230000002414 glycolytic effect Effects 0.000 description 1
• 102000035122 glycosylated proteins Human genes 0.000 description 1
• 108091005608 glycosylated proteins Proteins 0.000 description 1
• 208000027096 gram-negative bacterial infections Diseases 0.000 description 1
• 239000005090 green fluorescent protein Substances 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 description 1
• 229910052736 halogen Inorganic materials 0.000 description 1
• 150000002367 halogens Chemical class 0.000 description 1
• 230000009931 harmful effect Effects 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 210000005003 heart tissue Anatomy 0.000 description 1
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
• 210000003494 hepatocyte Anatomy 0.000 description 1
• 125000000623 heterocyclic group Chemical group 0.000 description 1
• 210000003630 histaminocyte Anatomy 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 238000010562 histological examination Methods 0.000 description 1
• 229920001519 homopolymer Polymers 0.000 description 1
• 230000028996 humoral immune response Effects 0.000 description 1
• 125000001165 hydrophobic group Chemical group 0.000 description 1
• 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
• MWFRVMDVLYIXJF-BYPYZUCNSA-N hydroxyethylcysteine Chemical compound OC(=O)[C@@H](N)CSCCO MWFRVMDVLYIXJF-BYPYZUCNSA-N 0.000 description 1
• 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
• 230000036543 hypotension Effects 0.000 description 1
• 230000002519 immonomodulatory effect Effects 0.000 description 1
• 208000026278 immune system disease Diseases 0.000 description 1
• 230000002584 immunomodulator Effects 0.000 description 1
• 230000003308 immunostimulating effect Effects 0.000 description 1
• 230000001506 immunosuppresive effect Effects 0.000 description 1
• 239000012535 impurity Substances 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 230000001939 inductive effect Effects 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 230000004941 influx Effects 0.000 description 1
• 230000015788 innate immune response Effects 0.000 description 1
• 238000011081 inoculation Methods 0.000 description 1
• 150000004001 inositols Chemical class 0.000 description 1
• 102000006495 integrins Human genes 0.000 description 1
• 108010044426 integrins Proteins 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 108090000681 interleukin 20 Proteins 0.000 description 1
• 108010045747 interleukin 3 receptor-like molecule Proteins 0.000 description 1
• 108040006870 interleukin-10 receptor activity proteins Proteins 0.000 description 1
• 108040003607 interleukin-13 receptor activity proteins Proteins 0.000 description 1
• 230000004073 interleukin-2 production Effects 0.000 description 1
• 229940100601 interleukin-6 Drugs 0.000 description 1
• 108040006858 interleukin-6 receptor activity proteins Proteins 0.000 description 1
• 229940096397 interleukin-8 Drugs 0.000 description 1
• XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 1
• 229940047122 interleukins Drugs 0.000 description 1
• 239000000543 intermediate Substances 0.000 description 1
• 201000002313 intestinal cancer Diseases 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 238000010253 intravenous injection Methods 0.000 description 1
• 239000001573 invertase Substances 0.000 description 1
• 235000011073 invertase Nutrition 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 210000002510 keratinocyte Anatomy 0.000 description 1
• 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• HXEACLLIILLPRG-RXMQYKEDSA-N l-pipecolic acid Natural products OC(=O)[C@H]1CCCCN1 HXEACLLIILLPRG-RXMQYKEDSA-N 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 230000021633 leukocyte mediated immunity Effects 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 230000033001 locomotion Effects 0.000 description 1
• 238000003670 luciferase enzyme activity assay Methods 0.000 description 1
• HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
• 231100000515 lung injury Toxicity 0.000 description 1
• 210000004324 lymphatic system Anatomy 0.000 description 1
• 230000000527 lymphocytic effect Effects 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 229920001427 mPEG Polymers 0.000 description 1
• 229960003511 macrogol Drugs 0.000 description 1
• 230000005291 magnetic effect Effects 0.000 description 1
• 210000001161 mammalian embryo Anatomy 0.000 description 1
• 230000013011 mating Effects 0.000 description 1
• SKEFKEOTNIPLCQ-LWIQTABASA-N mating hormone Chemical compound C([C@@H](C(=O)NC(CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCS(C)=O)C(=O)NC(CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CN=CN1 SKEFKEOTNIPLCQ-LWIQTABASA-N 0.000 description 1
• VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 230000034217 membrane fusion Effects 0.000 description 1
• 210000003584 mesangial cell Anatomy 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 229960000485 methotrexate Drugs 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 208000001725 mucocutaneous lymph node syndrome Diseases 0.000 description 1
• 210000004877 mucosa Anatomy 0.000 description 1
• 230000036457 multidrug resistance Effects 0.000 description 1
• 210000000066 myeloid cell Anatomy 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 230000037125 natural defense Effects 0.000 description 1
• 230000009826 neoplastic cell growth Effects 0.000 description 1
• 201000001119 neuropathy Diseases 0.000 description 1
• 230000007823 neuropathy Effects 0.000 description 1
• 230000003448 neutrophilic effect Effects 0.000 description 1
• 229910052759 nickel Inorganic materials 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 210000000287 oocyte Anatomy 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 210000000963 osteoblast Anatomy 0.000 description 1
• 210000002997 osteoclast Anatomy 0.000 description 1
• YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
• 150000002924 oxiranes Chemical class 0.000 description 1
• 230000020477 pH reduction Effects 0.000 description 1
• 238000004806 packaging method and process Methods 0.000 description 1
• 229940055729 papain Drugs 0.000 description 1
• 235000019834 papain Nutrition 0.000 description 1
• 230000005298 paramagnetic effect Effects 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 230000007310 pathophysiology Effects 0.000 description 1
• XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
• 201000001245 periodontitis Diseases 0.000 description 1
• 210000004976 peripheral blood cell Anatomy 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 208000033808 peripheral neuropathy Diseases 0.000 description 1
• 235000020030 perry Nutrition 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• RXNXLAHQOVLMIE-UHFFFAOYSA-N phenyl 10-methylacridin-10-ium-9-carboxylate Chemical compound C12=CC=CC=C2[N+](C)=C2C=CC=CC2=C1C(=O)OC1=CC=CC=C1 RXNXLAHQOVLMIE-UHFFFAOYSA-N 0.000 description 1
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
• 101150009573 phoA gene Proteins 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
• 108010085336 phosphoribosyl-AMP cyclohydrolase Proteins 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 230000001766 physiological effect Effects 0.000 description 1
• 230000035479 physiological effects, processes and functions Effects 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 108010031345 placental alkaline phosphatase Proteins 0.000 description 1
• 238000013439 planning Methods 0.000 description 1
• 239000003123 plant toxin Substances 0.000 description 1
• 230000004983 pleiotropic effect Effects 0.000 description 1
• 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
• 229920001583 poly(oxyethylated polyols) Polymers 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 229920002647 polyamide Polymers 0.000 description 1
• 238000006116 polymerization reaction Methods 0.000 description 1
• 102000054765 polymorphisms of proteins Human genes 0.000 description 1
• 229920001451 polypropylene glycol Polymers 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 229920002451 polyvinyl alcohol Polymers 0.000 description 1
• 235000020004 porter Nutrition 0.000 description 1
• 230000034190 positive regulation of NF-kappaB transcription factor activity Effects 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 239000002244 precipitate Substances 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 239000002987 primer (paints) Substances 0.000 description 1
• 230000037452 priming Effects 0.000 description 1
• 230000007112 pro inflammatory response Effects 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 210000001236 prokaryotic cell Anatomy 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• 230000001681 protective effect Effects 0.000 description 1
• 238000000159 protein binding assay Methods 0.000 description 1
• 238000000455 protein structure prediction Methods 0.000 description 1
• 230000017854 proteolysis Effects 0.000 description 1
• 230000002797 proteolythic effect Effects 0.000 description 1
• 210000001938 protoplast Anatomy 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 229950010131 puromycin Drugs 0.000 description 1
• 239000002510 pyrogen Substances 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 238000012950 reanalysis Methods 0.000 description 1
• 101150079601 recA gene Proteins 0.000 description 1
• 238000001525 receptor binding assay Methods 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 230000007115 recruitment Effects 0.000 description 1
• 210000000664 rectum Anatomy 0.000 description 1
• 230000000306 recurrent effect Effects 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 238000006722 reduction reaction Methods 0.000 description 1
• 230000027425 release of sequestered calcium ion into cytosol Effects 0.000 description 1
• 230000008439 repair process Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 239000012508 resin bead Substances 0.000 description 1
• 208000023504 respiratory system disease Diseases 0.000 description 1
• 230000004043 responsiveness Effects 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 238000004007 reversed phase HPLC Methods 0.000 description 1
• 238000011764 rheumatoid arthritis animal model Methods 0.000 description 1
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 238000007423 screening assay Methods 0.000 description 1
• 238000010845 search algorithm Methods 0.000 description 1
• JRPHGDYSKGJTKZ-UHFFFAOYSA-K selenophosphate Chemical compound [O-]P([O-])([O-])=[Se] JRPHGDYSKGJTKZ-UHFFFAOYSA-K 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 239000004017 serum-free culture medium Substances 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 108091006024 signal transducing proteins Proteins 0.000 description 1
• 102000034285 signal transducing proteins Human genes 0.000 description 1
• 230000007781 signaling event Effects 0.000 description 1
• 108091005475 signaling receptors Proteins 0.000 description 1
• 230000037432 silent mutation Effects 0.000 description 1
• 239000012279 sodium borohydride Substances 0.000 description 1
• 229910000033 sodium borohydride Inorganic materials 0.000 description 1
• BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
• 239000002689 soil Substances 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 238000000527 sonication Methods 0.000 description 1
• 238000001179 sorption measurement Methods 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 238000010186 staining Methods 0.000 description 1
• 230000036262 stenosis Effects 0.000 description 1
• 208000037804 stenosis Diseases 0.000 description 1
• 108010018381 streptavidin-binding peptide Proteins 0.000 description 1
• 208000025889 stromal keratitis Diseases 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 238000010254 subcutaneous injection Methods 0.000 description 1
• 239000007929 subcutaneous injection Substances 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 238000004441 surface measurement Methods 0.000 description 1
• 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
• 238000000672 surface-enhanced laser desorption--ionisation Methods 0.000 description 1
• 238000004114 suspension culture Methods 0.000 description 1
• 230000008961 swelling Effects 0.000 description 1
• 210000001179 synovial fluid Anatomy 0.000 description 1
• 210000001258 synovial membrane Anatomy 0.000 description 1
• 210000005222 synovial tissue Anatomy 0.000 description 1
• 238000010189 synthetic method Methods 0.000 description 1
• 230000006231 tRNA aminoacylation Effects 0.000 description 1
• NPDBDJFLKKQMCM-UHFFFAOYSA-N tert-butylglycine Chemical compound CC(C)(C)C(N)C(O)=O NPDBDJFLKKQMCM-UHFFFAOYSA-N 0.000 description 1
• 229960000814 tetanus toxoid Drugs 0.000 description 1
• 229960002180 tetracycline Drugs 0.000 description 1
• 229930101283 tetracycline Natural products 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• 229940126585 therapeutic drug Drugs 0.000 description 1
• 150000003573 thiols Chemical class 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• 229920001733 tresyl monomethoxy PEG Polymers 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• 229910052722 tritium Inorganic materials 0.000 description 1
• 201000008827 tuberculosis Diseases 0.000 description 1
• 210000004881 tumor cell Anatomy 0.000 description 1
• 102000003390 tumor necrosis factor Human genes 0.000 description 1
• 230000006433 tumor necrosis factor production Effects 0.000 description 1
• 230000005951 type IV hypersensitivity Effects 0.000 description 1
• 208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 230000036269 ulceration Effects 0.000 description 1
• 238000000108 ultra-filtration Methods 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 230000003827 upregulation Effects 0.000 description 1
• 150000003673 urethanes Chemical class 0.000 description 1
• 239000004474 valine Substances 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 239000013603 viral vector Substances 0.000 description 1
• 230000000007 visual effect Effects 0.000 description 1
• 239000003021 water soluble solvent Substances 0.000 description 1
• 208000016261 weight loss Diseases 0.000 description 1
• 230000004580 weight loss Effects 0.000 description 1